| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2022-05-18 | Five Narrow Lane LP | Zosano Pharma Corp | 262,177 | 5.3% | EDGAR |
| SC 13G/A | 2021-01-05 | SABBY MANAGEMENT, LLC | Zosano Pharma Corp | 0 | 0.0% | EDGAR |
| SC 13G | 2020-03-16 | ARMISTICE CAPITAL, LLC | Zosano Pharma Corp | 2,853,921 | 5.0% | EDGAR |
| SC 13G | 2020-03-13 | INTRACOASTAL CAPITAL, LLC | Zosano Pharma Corp | 2,160,835 | 3.0% | EDGAR |
| SC 13G | 2020-02-21 | ARMISTICE CAPITAL, LLC | Zosano Pharma Corp | 1,905,665 | 5.0% | EDGAR |
| SC 13G/A | 2020-02-14 | Flint Ridge Capital LLC | Zosano Pharma Corp | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-02-12 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Zosano Pharma Corp | 1,000,000 | 4.9% | EDGAR |
| SC 13G | 2020-02-12 | SABBY MANAGEMENT, LLC | Zosano Pharma Corp | 3,576,491 | 10.0% | EDGAR |
| SC 13G | 2019-10-15 | Flint Ridge Capital LLC | Zosano Pharma Corp | 785,000 | 4.4% | EDGAR |
| SC 13G/A | 2019-01-04 | SABBY MANAGEMENT, LLC | Zosano Pharma Corp | 167,403 | 1.4% | EDGAR |
| SC 13G | 2018-07-05 | Amzak Capital Management, LLC | Zosano Pharma Corp | 794,000 | 6.6% | EDGAR |
| SC 13G | 2018-04-09 | Aisling Capital IV, LP | Zosano Pharma Corp | 1,600,000 | 13.4% | EDGAR |
| SC 13G | 2018-04-06 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Zosano Pharma Corp | 1,000,000 | 8.4% | EDGAR |
| SC 13G | 2018-04-05 | NEXTHERA CAPITAL LP | Zosano Pharma Corp | 700,000 | 5.9% | EDGAR |
| SC 13G | 2018-03-29 | SABBY MANAGEMENT, LLC | Zosano Pharma Corp | 600,000 | 5.0% | EDGAR |
| SC 13G/A | 2018-02-14 | LILLY ELI & CO | Zosano Pharma Corp | 1,363,636 | 3.5% | EDGAR |
| SC 13G/A | 2018-02-14 | ARMISTICE CAPITAL, LLC | Zosano Pharma Corp | 0 | 0.0% | EDGAR |
| SC 13G/A | 2018-02-13 | Atlantic Trust Group, LLC | Zosano Pharma Corp | 103,132 | 5.2% | EDGAR |
| SC 13G | 2018-02-13 | Atlantic Trust Group, LLC | Zosano Pharma Corp | 103,132 | 5.2% | EDGAR |
| SC 13G/A | 2018-02-09 | Rosalind Advisors, Inc. | Zosano Pharma Corp | 32,500 | 1.6% | EDGAR |